Charles A. Reinhart, III
2016
In 2016, Charles A. Reinhart, III earned a total compensation of $2.4M as Chief Financial Officer at Pacira Pharmaceuticals.
Compensation breakdown
| Bonus | $85,500 |
|---|---|
| Option Awards | $2,024,368 |
| Salary | $269,231 |
| Other | $32,101 |
| Total | $2,411,200 |
Reinhart received $2M in option awards, accounting for 84% of the total pay in 2016.
Reinhart also received $85.5K in bonus, $269.2K in salary and $32.1K in other compensation.
Rankings
In 2016, Charles A. Reinhart, III's compensation ranked 4,076th out of 14,075 executives tracked by ExecPay. In other words, Reinhart earned more than 71.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,076 out of 14,075 | 71st |
Division Manufacturing | 1,428 out of 5,489 | 74th |
Major group Chemicals And Allied Products | 435 out of 1,895 | 77th |
Industry group Drugs | 316 out of 1,538 | 80th |
Industry Pharmaceutical Preparations | 248 out of 1,176 | 79th |
Source: SEC filing on April 21, 2017.
Reinhart's colleagues
We found five more compensation records of executives who worked with Charles A. Reinhart, III at Pacira Pharmaceuticals in 2016.
2016
David Stack
Pacira Pharmaceuticals
Chief Executive Officer
2016
James Scibetta
Pacira Pharmaceuticals
Chief Financial Officer
2016
Robert Weiland
Pacira Pharmaceuticals
Chief Commercial Officer
2016
Scott Braunstein
Pacira Pharmaceuticals
Senior Vice President, Strategy and Corporate Development
2016
Kristen Williams
Pacira Pharmaceuticals